Skip to main content
Equibles

Luis Peña

CEO

Evommune, Inc. (EVMN)

Board Member

Evommune, Inc. (EVMN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Evommune, Inc. publishes a filing, an earnings call transcript or a press release.

Get EVMN alerts

About Luis Peña

Luis Peña is recorded as CEO and Board Member at Evommune, Inc. (EVMN). The newest filing on record that lists Luis Peña as CEO and Board Member at Evommune, Inc. (EVMN) is dated April 21, 2026. The proxy statement of Evommune, Inc. reports total compensation of $11,022,670 for Luis Peña in fiscal 2025, including a base salary of $588,462. Disclosed compensation is on record for 2 fiscal years. Luis Peña has spoken on 1 investor event across 1 company, most recently for Evommune, Inc. on April 13, 2026. Evommune, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Evommune, Inc. includes Kyle Carver (CFO) and Eugene A. Bauer (Board Member).

Luis Peña on recent calls

“We're really looking forward today to introduce the migraine indication to the X2 program. As you have seen, we have now two programs that are in phase two development.”
CEO, KOL Webinar Highlighting Role of MRGPRX2 in Migraine ·

Affiliation history

Company network

Leadership on record at Evommune, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Evommune, Inc. (EVMN) $588,462 $11,022,670
2024 Evommune, Inc. (EVMN) $546,083 $7,444,605

Recent activity